These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15176166)

  • 1. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infliximab].
    Herrera E; Habicheyn S
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab and nephrotic syndrome.
    Chin G; Luxton G; Harvey JM
    Nephrol Dial Transplant; 2005 Dec; 20(12):2824-6. PubMed ID: 16204273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New development in the treatment of psoriasis--infliximab.
    Pietrzak A; Chodorowska G; Jazienicka I; Junak-Bojarska A; Roliński J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):322-7. PubMed ID: 15315008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy.
    Chan JL; Davis-Reed L; Kimball AB
    J Drugs Dermatol; 2004; 3(3):315-8. PubMed ID: 15176169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
    Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
    Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sickness-like reactions in patients receiving intravenous infliximab.
    Gamarra RM; McGraw SD; Drelichman VS; Maas LC
    J Emerg Med; 2006 Jan; 30(1):41-4. PubMed ID: 16434333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurological symptoms following infusion of infliximab].
    Bebe AC; Harboe KM; Nøjgaard C
    Ugeskr Laeger; 2012 Oct; 174(40):2388-90. PubMed ID: 23031302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.
    Winterfield L; Menter A
    Dermatol Clin; 2004 Oct; 22(4):437-47, ix. PubMed ID: 15450339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Legionella pneumonia in patients treated with infliximab].
    Vinter H; Nielsen HI
    Ugeskr Laeger; 2009 Jan; 171(4):247. PubMed ID: 19174042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Up-date on the use of infliximab in dermatology. Introduction].
    Sánchez-Carazo J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment.
    DE Oliveira JP; Levy A; Morel P; Guibal F
    J Dermatol; 2008 Sep; 35(9):575-80. PubMed ID: 18837702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.
    Lecluse LL; Piskin G; Mekkes JR; Bos JD; de Rie MA
    Br J Dermatol; 2008 Sep; 159(3):527-36. PubMed ID: 18627374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab.
    Kling MC; Larian AA; Scordi-Bello I; Emer J; Lebwohl MG
    Arch Dermatol; 2010 Jun; 146(6):651-4. PubMed ID: 20566928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
    Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.